Guardian Pharmacy Services revenue was $1.45B for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $397.6M, up 5.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GRDN annual revenue was $1.4B, with 17.9% growth year-over-year.
GRDN past revenue growth
How has GRDN's revenue growth performed historically?
On Invalid Date, Guardian Pharmacy Services (NYSE: GRDN) reported Q4 2025 revenue of $397.62 million up 17.44% year over year. In the same quarter last year, Guardian Pharmacy Services's revenue was $338.57 million.
What was Guardian Pharmacy Services's revenue in 2025?
Guardian Pharmacy Services's annual revenue for the twelve months ending Dec 31, 2025 was $1.45 billion, a 17.93% increase year over year.
How much does Guardian Pharmacy Services make in a day?
Based on Guardian Pharmacy Services annual revenue for the past three years, GRDN makes an average of $3,400,262.10 per day.
What was Guardian Pharmacy Services's annual revenue growth in the past year?
As of Q1 2026, Guardian Pharmacy Services's revenue has grown 17.93% year over year. This is 8.58 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 9.35%. Guardian Pharmacy Services's revenue in the past year totaled $1.45 billion.
How much does Guardian Pharmacy Services make in a year?
Guardian Pharmacy Services's revenue by year for the past three years is:
Guardian Pharmacy Services's revenue for the twelve months ending Dec 31, 2025 was $1.45 billion, a 17.93% increase year over year.
Guardian Pharmacy Services's annual revenue for Dec 31, 2024 was $1.23 billion, a 17.42% increase from 2023.
Guardian Pharmacy Services's annual revenue for 2023 was $1.05 billion, a 15.1% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.